A number of recent studies have attested to the broad spectrum of antibacterial activity for tobramycin, a new aminoglycoside antibiotic (5, 7, 9) . Its effectiveness in vitro is comparable with that of gentamicin, a chemically related aminoglycoside, against Staphylococcus aureus and certain species of Enterobacteriaceae, but most susceptible strains of Pseudomonas aeruginosa are inhibited by a lower concentration of tobramycin than gentamicin. Although resistance both to gentamicin and to tobramycin occurs in some bacterial strains, other isolates are either resistant to gentamicin and susceptible to tobramycin or resistant to tobramycin and susceptible to gentamicin (5) (6) (7) (8) (9) 15) . Resistance to aminoglycoside antibiotics in clinical isolates of bacteria is generally determined by R factors, although other mechanisms of resistance have been described. Some R factors have been shown to control the synthesis of enzymes that modify and inactivate clinically useful aminoglycosides (3) .
In this study we report transferable resistance to tobramycin associated with enzymatic acetylation of tobramycin and other aminoglycosides I Present address: Department of Surgery, University of Washington, Seattle, Wash. 98195. in Klebsiella pneumoniae and Enterobacter cloacae isolated from burn wounds. The acetylating activities from these strains resemble kanamycin acetyltransferase (KAT) in their specificities for aminoglycoside substrates. MATERIALS (1) .
Bacterial extracts and enzymatic assays. Osmotic lysates of bacterial cells were prepared by the procedure of Nossal and Heppel (14) , modified in our laboratory as previously described (11) .
Assays for the acetylation or adenylylation of aminoglycoside antibiotics used radioisotopically labeled acetyl coenzyme A or adenosine 5 Table 2 ). The differences in the frequency of transfer by the various donor strains were not significant. Transduction of tobramycin resistance was ruled out by demonstrating that no resistant colonies could be isolated when bacteria-free filtrates of exponential-phase cultures of the donors were incubated with RC703 rifr in the same manner as described for conjugation. Tobramycin-resistant transcipient colonies from the crosses in Table 2 were replica plated to MHBA containing kanamycin (30 ,g/ml) and to MHBA containing tetracycline (20 sg/ml). All tobramycin-resist- Table 2 were tested for susceptibility to other antibiotics by disk diffusion. All 15 transcipient colonies tested were resistant to neomycin, resistant or indeterminant to streptomycin and ampicillin, and susceptible to tetracycline and chloramphenicol. The recipient RC703 rifr was susceptible to all these antibiotics.
The MICs of tobramycin, gentamicin, and kanamycin were determined for the K. pneumoniae and E. cloacae donor sttains, the E. coli recipient strain, and five transcipients from each of three mating experiments ( Table 3) . The MICs for tobramycin and kanamycin were comparable in all of the donor and transcipient strains, but the MICs for gentamicin were slightly lower in the transcipients. Although the donor and transcipient strains were both susceptible to gentamicin (observed MIC, 2.5 to 7.5 ,ug/ml), they were two-to sixfold more resistant to gentamicin than was the recipient (MIC, 1.25 Ag/ml). When the susceptibility of these strains to the purified components gentamicin Cl, gentamicin Cla, and gentamicin C2 was compared, most of the transcipients were significantly more resistant than the recipient strain but more susceptible than the donor strains. The MICs for the recipient strain were 1.25 gg/ml for gentamicins Cl 12.5 Ag/ml for gentamicin Cla, and 1.25 to 7.5,ug/ml for gentamicin C2.
Enzymatic acetylation of tobramycin, gentamicin, and kanamycin was observed with osmotic lysates of the three donor strains, Kp355, Ec359, and Ec264, and of three transcipient strains, RC703 rif (R355), RC703 rinf (R359), and RC703 rig (R264). The R followed by a three digit number indicates that resistance to tobramycin was conjugally transferred from the donor strain identified by the same number. Adenylylation of gentamicin, tobramycin, or kanamycin was not detected with osmotic lysates of Kp355, Ec359, and Ec264.
The acetylation of various aminoglycoside antibiotics was assayed with osmotic lysates of strains Kp355 and Ec264 to determine the substrate specificities of the acetylating activities (Table 4) . Under the conditions of these assays, the acetyltransferases were active against kanamycins A and B, tobramycin, gentamicins Cla and C2, amikacin (BB-K8), sisomicin, and butirosin, but gentamicins A and Cl were not acetylated. The significance of the differences observed between the two enzyme preparations in the relative reaction rates with these aminoglycoside substrates has not been established. These results do indicate that the acetyltransferases from our strains resemble KAT. The properties of KAT have recently been reviewed by Benveniste and Davies (3).
DISCUSSION
The strains of K. pneumoniae, Escherichia coli, and Enterobacter cloacae listed in Table 1 were isolated from wound cultures of patients in the adult burn intensive care unit or in an adjacent hospital area. Detection of tobramycin-resistant, gentamicin-susceptible enteric bacteria from these cultures stimulated the present study. During the period of this study, tobramycin was used as an investigational drug only in patients with burns over more than 40% of the total body surface area who exhibited persistent signs of sepsis after a therapeutic trial with a combination of gentamicin and carbenicillin. Tobramycin at a total dose of 4 mg/kg per day was administered intramuscularly in divided doses.
One K. pneumoniae and two E. cloacae strains with similar antibiotic resistance patterns were isolated after the retrospective review and were studied to clarify the mechanisms of resistance to tobramycin and to " A rate of 100 was assigned for the acetylation of kanamycin. Other rates are expressed as relative values. The amount of product formed in 30 min per 60-,uliter reaction mixture in the kanamycin assay was 97.7 pmol for Kp355 and 885.3 pmol for Ec264. Under the conditions used, the reaction is linear for at least 30 min and the amount of acetylated product formed is proportional to the rate of the acetylation reaction.
determine whether tobramycin resistance might be determined by R factors. Resistances to tobramycin, kanamycin, and neomycin were cotransferred by conjugation from these resistant strains to E. coli (Table 2) , and the transcipient strains were shown to be resistant to high concentrations of tobramycin and kanamycin (Table 3) . Acetylation of tobramycin, gentamicin, and kanamycin was observed with osmotic lysates from the donor strains Kp355, Ec359, and Ec264 and from representative transcipients from the matings in Table 2 (Table 4) .
Although the aminoglycoside-acetylating activity in our strains appeared to be KAT, both our donor strains and our E. coli transcipients were resistant to high concentrations of tobramycin (MIC, 25 to 50 gg/ml). In addition, the transcipients were more resistant to gentamicin complex, to gentamicin Cl, to gentamicin Cla, and to gentamicin C2 than was the recipient strain. In contrast, Benveniste and Davies studied E. coli carrying R factors that determined the production of KAT and resistance to kanamycin, but the R+ strain was susceptible to tobramycin (MIC, 7 gg/ml) (2) . They also reported that the acetylated derivative of tobramycin formed by KAT retained some antibiotic activity (3). Among aminoglycoside-resistant bacteria, Price et al. (15) reported the possible presence of KAT in only one isolate of E. coli, and that strain was resistant to tobramycin. For treatmIrrent of experimental infections in animals, Price et al. (15) found that tobramycin, gentamicin, kanamycin, and amikacin (BB-K8) were more effective against E. coli than P. aeruginosa, although both strains produced KAT. Thus, the presence of KAT in bacteria can be associated either with resistance or with susceptibility to tobramycin.
Although reasons for variability of resistance to tobramycin in KAT-producing bacterial strains have not been clarified, two types of mechanisms should be considered: differences in the activity of KAT among KAT-producing bacteria, and the presence or absence of other resistance determinants in addition to the determinant for KAT. Since the acetylated derivative of tobramycin formed by KAT is active as an antibiotic, the first explanation seems unlikely. Resistance to aminoglycosides that is not determined by enzymatic inactivation of the antibiotic has been described by several investigators, and such mechanisms could be relevant to the altered susceptibility to tobramycin and gentamicin in our KAT-producing strains.
Streptomycin resistance due to mutational alterations in ribosomal proteins has been studied in detail in E. coli (3). Bryan has described gentamicin-resistant strains of P. aeruginosa that do not produce gentamicin-modifying enzymes and has shown that they are less permeable to gentamicin than are susceptible strains of P. aeruginosa (R. Haraphongse and L. E. Bryan, Prog. Abstr. Intersci. Conf. Antimicrob. Ag. Chemother., 13th, Washington, D.C., Abstr. 185, 1973) . Lundbiick and Norstrom (12) have recently studied mutants of E. coli carrying R factors that determine enzymatically mediated resistance to low concentrations of streptomycin and have shown that a chromosomal mutation can act synergistically with the R factors to produce high-level streptomycin resistance. Although it is well established that R factors can confer simultaneous resistance to multiple antibiotics, the possibility that individual R factors may be capable of determining several mechanisms of resistance to a single antibiotic agent deserves further investigation. Additional studies should reveal whether or not the synergistic interaction of multiple-resistance mechanisms is important in determining resistance to very high concentrations of some antibiotics in clinical isolates of bacteria.
